Plant-based

Medicinal cannabis
#Addiction #Cannabinoid #Medicinal cannabis #Plant-based

Cutting a path through the weeds with cannabis research

Dr Currien MacDonald, Medical Chair Director at WCG, discusses the challenges and opportunities presented by cannabis research. The recent interest in cannabinoids as potential sources for medicinal use has been a long time coming. Advances in brain science and modern chemistry are supporting a new generation of investigation into cannabinoids,… Read More

#Exclusive Content

#Antimicrobial resistance (AMR) #Cell and gene therapy #Europe #Immunology / Virology & Vaccines #Market reporting #mRNA #Plant-based

Read the Spring issue of DDW now

The Spring issue of Drug Discovery World (DDW) is out now. It looks at where we are in the fight against antimicrobial resistance, explores how structural biology is informing vaccine design, and offers advice on approaching dealmaking in biopharma. Read the digital version here. … Read More

#News

Plant-based concept
#Bio Studio #Bioma #Chronic pain #Mental health #Plant-based #Start-ups

Tackling pain and mental health with plant-based medicines

DDW Editor Reece Armstrong speaks to Michael Krogh Jensen, Co-founder and CEO of Biomia, about developing plant-based medicines and what recent investment and support from the Bio Studio programme means for its pipeline. RA: How has being part of the Bio Studio programme helped you develop your pipeline? MJ: The… Read More

#Exclusive Content #Start-up Zone

Traumatic brain injury
#Brain injury #Neuroscience #Plant-based #Psychiatry #PTSD #Stanford University

Plant-based psychoactive drug treats traumatic brain injury

New research has found that plant-based psychoactive drug ibogaine improved depression, anxiety and functioning among veterans with traumatic brain injuries (TBI). TBI from head trauma or blast explosions are a leading cause of post-traumatic stress disorder (PTSD), anxiety, depression and suicide among veterans. Stanford… Read More

#News #Trending News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

New DDW Highlights podcast: 4 December 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The key drug discovery news this week focuses on experimental approaches to… Read More

#News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

This week in drug discovery (27 Nov – 1 Dec) 

News round-up for 27 November – 1 December by DDW Digital Content Editor Diana Spencer. The key drug discovery news this week focuses on experimental approaches to the treatment of some of the most challenging diseases, including a mathematical model that can simulate Alzheimer’s progression and… Read More

#News

Flower of Oldenlandia monanthos
#Drug discovery #Plant-based #Proteins #University of Bath

Can a plant-based discovery pave the way for new drug treatments?

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. Drug treatments often… Read More

#News

Seed fund
#BioInnovation Institute #Financing #Mental health #Plant-based #Start-ups

$3M funding for plant-inspired halogenated small molecule drugs

Biomia, the first company spun out from BioInnovation Institute’s Bio Studio programme, has secured $3 million in pre-seed financing from an international syndicate of investors. Biomia says it plans to use the investment to accelerate its development of plant-inspired natural and new-to-nature halogenated small molecule drug candidates and further build… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery #Plant-based #Therapeutics

Where is the promise for plant-based medicines? Part 3 

In the third and final part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates therapeutic breakthroughs using plant-based products in drug discovery. The first part of the series explored medical cannabis, and the second looked into psylocibin.   Green tea   Epigallocatechin gallate (EGCG), also known as… Read More

#Exclusive Content #Opinion #Regulatory

Magic Mushrooms in laboratory. Psilocybin science and research.
#Depression #Plant-based #Psilocybin #Psychedelics #Treatment-resistant depression

Where is the promise for plant-based medicines? Part 2: Psilocybin 

In the second part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of psilocybin in drug discovery. The first part explored medical cannabis.  What is the regulatory landscape of psilocybin?  Psilocybin is a naturally occurring psychedelic compound that is produced by more than… Read More

#Business & Investment #Exclusive Content #Regulatory

Science, Safety, Research, Technology and Cannabis
#Cannabinoid #Medicinal cannabis #Plant-based #Regulatory

Where is the promise for plant-based medicines? Part 1: Cannabis  

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. What is the regulatory landscape of medical cannabis?  Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due… Read More

#Exclusive Content #Regulatory #Trends & Analysis

Raphael Mechoulam
#Cannabinoid #Medicinal cannabis #Obituary #Plant-based #THC

The ‘father of cannabis research’ dies aged 92

World pioneer in cannabis research, Professor Raphael Mechoulam, has died in Israel at the age of 92. A professor in the Hebrew University School of Pharmacy, Mechoulam began his cannabinoid experiments in the 1960s in Israel. His research team was the first to isolate… Read More

#News

Medicinal cannabis
#Cannabinoid #Clinical trials #Medicinal cannabis #Plant-based

Medicinal cannabis: Why more clinical trials and better access is needed

Listen to this article on the DDW podcast: Michael Sassano, CEO at SOMAÍ Pharmaceuticals looks at what’s needed throughout Europe to help increase access to medicinal cannabis and the current state of pharmaceutical research in this area. The use of medicinal cannabis across much of the world is still in its… Read More

#Exclusive Content

#Biologics / Biotechnology #Cell and gene therapy #Covid-19 #Drug discovery #mRNA-based vaccines #Plant-based #Synthetic biology #Ukraine

DDW’s best of 2022: What were your top reads?

2022 was a complicated year. Global challenges like the Ukraine war and the continued impact of Covid-19 have been felt across the world. And yet it was also a year of incredible innovation in drug discovery, with the potential of new biotechnology beginning to be revealed. Our top 10 most… Read More

#Editor's Choice #Exclusive Content #News

Amaranth oil
#Biopharmaceuticals #Drug discovery #Immunology / Virology & Vaccines #Plant-based

Plant-based squalene alternative suitable for vaccine use

Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It is an alternative to animal-derived squalene, which for pharmaceutical applications is typically sourced from shark liver oil. Read More

#News